179 related articles for article (PubMed ID: 9324176)
1. Pharmacokinetics of azithromycin after single- and multiple-doses in children.
Stevens RC; Reed MD; Shenep JL; Baker DK; Foulds G; Luke DR; Blumer JL; Rodman JH
Pharmacotherapy; 1997; 17(5):874-80. PubMed ID: 9324176
[TBL] [Abstract][Full Text] [Related]
2. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
Torkildsen G; O'Brien TP
Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788
[TBL] [Abstract][Full Text] [Related]
3. Disposition of oral azithromycin in humans.
Luke DR; Foulds G
Clin Pharmacol Ther; 1997 Jun; 61(6):641-8. PubMed ID: 9209246
[TBL] [Abstract][Full Text] [Related]
4. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of azithromycin after intravenous and intramuscular administration to goats.
Cárceles CM; Font A; Espuny A; Fernández-Varón E; Serrano JM; Escudero E
J Vet Pharmacol Ther; 2005 Feb; 28(1):51-5. PubMed ID: 15720515
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder.
Boellner SW; Pennick M; Fiske K; Lyne A; Shojaei A
Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079
[TBL] [Abstract][Full Text] [Related]
7. Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg.
Danesi R; Lupetti A; Barbara C; Ghelardi E; Chella A; Malizia T; Senesi S; Angeletti CA; Del Tacca M; Campa M
J Antimicrob Chemother; 2003 Apr; 51(4):939-45. PubMed ID: 12654753
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intravenously administered azithromycin in pediatric patients.
Jacobs RF; Maples HD; Aranda JV; Espinoza GM; Knirsch C; Chandra R; Fisher JM; Kearns GL
Pediatr Infect Dis J; 2005 Jan; 24(1):34-9. PubMed ID: 15665708
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
[TBL] [Abstract][Full Text] [Related]
10. A study of the pharmacokinetics of azithromycin and nelfinavir when coadministered in healthy volunteers.
Amsden GW; Nafziger AN; Foulds G; Cabelus LJ
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1522-7. PubMed ID: 11185676
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
12. Once-daily gentamicin dosing in pediatric patients without cystic fibrosis.
McDade EJ; Wagner JL; Moffett BS; Palazzi DL
Pharmacotherapy; 2010 Mar; 30(3):248-53. PubMed ID: 20180608
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
Mao ZL; Stalker D; Keirns J
Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of palifermin administered as the standard dose and as a collapsed dose in patients with hematologic malignancies.
Zia-Amirhosseini P; Hurd DD; Salfi M; Cheah TC; Aycock J; Cesano A
Pharmacotherapy; 2007 Oct; 27(10):1353-60. PubMed ID: 17896890
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of azithromycin in trachoma patients: serum and tear levels.
Karcioglu ZA; El-Yazigi A; Jabak MH; Choudhury AH; Ahmed WS
Ophthalmology; 1998 Apr; 105(4):658-61. PubMed ID: 9544640
[TBL] [Abstract][Full Text] [Related]
18. Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.
Girard D; Finegan SM; Dunne MW; Lame ME
J Antimicrob Chemother; 2005 Aug; 56(2):365-71. PubMed ID: 16002421
[TBL] [Abstract][Full Text] [Related]
19. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children.
Tran A; Rey E; Pons G; Pariente-Khayat A; D'Athis P; Sallerin V; Dupont C
Clin Pharmacol Ther; 2002 May; 71(5):359-67. PubMed ID: 12011821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
